Chevron Doctrine’s Dismissal Has Yet to Upend Regulatory Environment
However, clinical laboratories may have more say in future laws and guidance thanks to 2024 decision
FDA-lca
Subscribe today for access to
Articles and Reports
FDA Watch: Mass Spectrometry Test Receives First Moderate Complexity Designation
Roche’s vitamin D assay includes internal quality controls that allowed it to obtain the CLIA designation
FDA Watch: BD Receives FDA Approval for Veritor, a Pandemic Staple
The assay was widely used during the early months of COVID-19 and was a significant source of revenue growth for a time
FDA’s 2016 Guidance Plans Include LDTs and Other Diagnostics Topics
...
Already a member? Log in here
FDA Workshop Addresses Security of Medical Devices
From - G2 Compliance Advisor
The U.S. Food and Drug Administration (FDA) is joining the cadre of government agencies calling attention to the cybersecurity risks of wireless, internet-and network-connected devices and…
FDA and CMS Address LDT Regulation Before Energy and Commerce Committee
...
Already a member? Log in here
FDA Details Oversight of Medical Applications On Smart Phones and Tablets
...
Already a member? Log in here
Final FDA Guidance on RUO, IUO Products Raises Compliance Concerns for Labs
...
Already a member? Log in here
- « Previous
- 1
- …
- 4
- 5
- 6